Glucose Health (OTCMKTS:GLUC) Releases Earnings Results

Glucose Health (OTCMKTS:GLUC – Get Free Report) announced its earnings results on Monday. The company reported ($0.01) earnings per share (EPS) for the quarter, Zacks reports. The business had revenue of $0.05 million for the quarter.

Glucose Health Stock Performance

GLUC remained flat at $0.30 on Wednesday. 27,300 shares of the company traded hands, compared to its average volume of 18,329. The stock’s 50 day simple moving average is $0.36 and its 200 day simple moving average is $0.36. Glucose Health has a 52 week low of $0.13 and a 52 week high of $0.67. The stock has a market cap of $8.54 million, a price-to-earnings ratio of -10.00 and a beta of 1.30.

Recent Glucose Health Headlines

Investors following GLUC have been watching these headlines:

About Glucose Health

(Get Free Report)

Glucose Health, Inc. is a consumer health company focused on nutritional products designed to support healthy blood sugar levels. Its principal product is Glucose Health® Blood Sugar Support Drink Mix, a powdered beverage marketed for people seeking a convenient addition to their daily wellness routine. The company’s product is positioned as nutritional support, not as a treatment for diabetes or other medical conditions.

Featured Articles

Earnings History for Glucose Health (OTCMKTS:GLUC)

Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.